Jae-Ll Park

WNT5A-RHOA signaling is a driver of tumorigenesis and represents a therapeutically actionable vulnerability in small cell lung cancer.

Kwon-Sik Park, Kee-Beom Kim, B. Fang, 2022, Cancer Research.

E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming

J. Ajani, Sohee Jun, Shumei Song, 2024, The Journal of experimental medicine.

CRACD loss induces neuroendocrine cell plasticity of lung adenocarcinoma.

Sohee Jun, Jie Zhang, Youn-Sang Jung, 2024, Cell reports.

In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.

Dan Su, Zhen Chen, Mengfan Tang, 2024, Proceedings of the National Academy of Sciences of the United States of America.